Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...
Development of effective medications for central nervous system (CNS) disorders has long been plagued by a high failure rate in clinical trials. One ...
In a study appearing in Nature Catalysis, researchers from the Inorganic Chemistry Department of the Fritz Haber Institute ...